A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations
A Pilot Study to Optimize Imaging When Utilizing the PINPOINT Endoscopic Fluorescence Imaging System for Identification of Biliary Anatomy During Laparoscopic Biliary and Hepatic Operations
1 other identifier
interventional
38
1 country
1
Brief Summary
Operations on the liver, bile ducts, and gallbladders are some of the most commonly performed abdominal operations in the United States. Cholecystectomy, removal of the gallbladder, is the most common of these with more than 750,000 performed annually. Injury to the common bile duct (CBD) during these procedures occur infrequently (approximately 0.1% to 0.5%), but it is an important source of patient morbidity. Serious injuries often require at least one surgical repair, and these repairs have variable long-term outcomes. Techniques to allow the visualization of the bile ducts may prevent such an injury, by providing vital information about the presence of gallstones in the CBD and show a surgical road map of the ducts. Near-infrared (NIR) cholangiography has the advantage over standard cholangiography of not exposing patients and healthcare providers to radiation. This technique also allows the superimposition of the cholangiogram onto the normal image. This study is being conducted to optimize an imaging technique called PINPOINT. Images will be obtained during clinically necessary operations. The images will be evaluated to determine the best method for locating and outlining the anatomy. The information learned will guide the future use of PINPOINT in laparoscopic procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Jan 2014
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 19, 2014
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedDecember 2, 2014
December 1, 2014
10 months
February 19, 2014
December 1, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
Ease of Identification of Biliary Anatomy as Scored by the Surgeon (1-5 scale)
10 minutes after injection
Ease of Identification of Biliary Anatomy as Scored by the Surgeon (1-5 scale)
45 minutes after injection
Study Arms (2)
Group 1
EXPERIMENTALICG administered 10 minutes prior to time of visualization
Group 2
EXPERIMENTALICG administered 45 min prior to time of visualization
Interventions
Eligibility Criteria
You may qualify if:
- To be eligible for the study, subjects must fulfill all of the following criteria:
- Subjects who are healthy men or women 18 years of age or older.
- Subjects who are scheduled for laparoscopic biliary or hepatic operations.
- Subjects who sign an approved informed consent form for the study.
- Subjects who are willing to comply with the protocol.
You may not qualify if:
- Subjects meeting any of the following criteria will be excluded from the study:
- Subjects with a known allergy or history of adverse reaction to ICG, iodine or iodine dyes.
- Subjects who, in the Investigator's opinion, have any medical condition that makes the subject a poor candidate for the investigational procedure, or interferes with the interpretation of study results.
- Subjects who are pregnant or lactating females.
- Subjects, who are actively participating in another investigational clinical study and who, in the Investigator's or Sponsor's opinion, should not be enrolled in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095, United States
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 19, 2014
First Posted
February 24, 2014
Study Start
January 1, 2014
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
December 2, 2014
Record last verified: 2014-12